LY2811376 is the first orally available non-peptidic β-secretase ( BACE1 ) inhibitor with IC 50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC 50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2 , and more than 50-fold inhibition over other aspartic proteases including cathepsin D , pepsin, or renin .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Beta-secretase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。